维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Graefe U"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A reference model for production control 显示文摘	Graefe U Thomson V	1989	International Journal of Computer Integrated Manufacturing1989，2，2：	1
2	Identificationof quercetin glucuronides in human plasma by high-performanceliquid chromatography-tandem mass spectrometry显示文摘	WITTIG J HERDERICH M GRAEFE E U	2001	Journal ofChromatography B2001，753，：	1
3	Agricultural practice changes with cultivating genetically modified herbicide-tolerant oilseed rape显示文摘	Graef F Stachow U Werner A	2007	Agricultural Systems2007，94，：	1
4	Sedation assessment in criticaly ill patients with bispectral index 显示文摘	Riess M L Graefe U A Goeters C	2002	Eur J Anaesthesiol2002，19，1：	1
5	Large B-cell lymphoma of theleg-complete remission with perilesional interferon alpha 显示文摘	Wollina U Mentzel T Graefe T	2001	Dermatology2001，203，2：	1
6	Pseudoainhum of all fingers associated with Reynolds'syndrome and breast cancer: report of a case and review of the literature显示文摘	Wollina U Graefe T Oelzner P	2001	J Am Acad Dermatol2001，44，2：	1
7	Isolation and structure elucidation of tyramine and indole alkaloids from antarctic strain Microbispora aerata Imbas-11A显示文摘	Ivanova V Graefe U Schlegel R		0，，02：	1
8	Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart显示文摘	CARLSSON L GRAEFE K H TRENDELENBURG U	1987	Naunyn Schmiedebergs Arch Pharmacol1987，336，：	1
9	Pharmacokinetics of linagliptin in subjects with hepatic impairment显示文摘	Graefe Mody U Rose P Retlich S		0，，1：	1
10	Pharmacokinetics and bioavailability of quercetin glycosides in humans显示文摘	Graefe E U Wittig J Mueller S	2001	Journal of Clinical Pharmacology2001，41，5：	1
11	Effect of linagliptin(BI 1356)on the steady-state pharmacokinetics of simvastatin显示文摘	Graefe Mody U Huettner S Stahle H		0，，6：	1
12	Effect of linagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers显示文摘	Graefe Mody E U Brand T Ring A		0，，5：	1
13	Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DDP-4 inhibitor linagliptin and metformin in healthy subjects显示文摘	Graefe Mody E U Padula S Ring A		0，，8：	1
14	Evaluation of pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy voluntee-rs显示文摘	Graefe Mody E U Jungnik A Ring A		0，，10：	1
15	Assessment of the pharmacokinetic interaction between the novel DDP-4 inhibitor linagliptin and a sulfonylurea,glyburide,in healthy subjects显示文摘	Graefe Mody U Rose P Ring A		0，，2：	1
16	Information system for monitoring environmental impacts of genetically modified organisms显示文摘	Reuter H Middelhoff U Graef F	2010	Environ Sci Pollut Res2010，17，：	1
17	Informa-tion system for monitoring environmental impacts of geneticallymodified organisms 显示文摘	REUTER H MIDDLELHOFF U GRAEF F	2010	Environmental Science and PollutionResearch2010，17，8：	1
18	Pharmacokinetics and bioavailability of quercetin glycosides in humans 显示文摘	Graefe E U Wittig J Mueller S	2001	J Clin Pharmacol2001，41，5：	1
19	A reference model for production con- trol显示文摘	GRAEFE U THOMSON V	1989	International Journal of Computer Integrated Manufactur- ing1989，2，2：	1
20	Usefulness of bispectral index to assess the level of sedation in critically ill patients显示文摘	Riess M L Graefe U A Van Aken H	1999	Crit Care Med1999，27，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示